Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients
Maksymowych WP et al. Rheumatology (Oxford) 2018; Advance online publication. doi: 10.1093/rheumatology/key104
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.